Literature DB >> 24798715

Cleveland Clinic's Center for personalized healthcare: setting the stage for value-based care.

Kathryn Teng1, Jennifer DiPiero, Thad Meese, Megan Doerr, Mandy Leonard, Thomas Daly, Felicitas Lacbawan, Jeff Chalmers, David Stowe, Scott Knoer, J Kevin Hicks.   

Abstract

Cleveland Clinic (OH, USA) launched the Center for Personalized Healthcare in 2011 to establish an evidence-based system for individualizing care by incorporating unique patient characteristics, including but not limited to genetic and family health history information, into the standard medical decision-making process. Using MyFamily, a web-based tool integrated into our electronic health record, a patient's family health history is used as a surrogate for genetic, environmental and behavioral risks to identify those with an elevated probability of developing disease. Complementing MyFamily, the Personalized Medication Program was created for the purpose of identifying gene-drug pairs for integration into clinical practice and developing the implementation tools needed to incorporate pharmacogenomics into the clinical workflow. We have successfully implemented the gene-drug pairs HLA-B*57:01-abacavir and TPMT-thiopurines into patient care. Our efforts to establish personalized medical care at Cleveland Clinic may serve as a model for large-scale integration of personalized healthcare.

Entities:  

Mesh:

Year:  2014        PMID: 24798715     DOI: 10.2217/pgs.14.31

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  4 in total

Review 1.  Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.

Authors:  Evangelia Eirini Tsermpini; Zeina N Al-Mahayri; Bassam R Ali; George P Patrinos
Journal:  Hum Genet       Date:  2021-10-01       Impact factor: 4.132

Review 2.  Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development.

Authors:  Marc Hinderer; Martin Boeker; Sebastian A Wagner; Martin Lablans; Stephanie Newe; Jan L Hülsemann; Michael Neumaier; Harald Binder; Harald Renz; Till Acker; Hans-Ulrich Prokosch; Martin Sedlmayr
Journal:  BMC Med Inform Decis Mak       Date:  2017-06-06       Impact factor: 2.796

3.  Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.

Authors:  Kathrin Blagec; Rudolf Koopmann; Mandy Crommentuijn-van Rhenen; Inge Holsappel; Cathelijne H van der Wouden; Lidija Konta; Hong Xu; Daniela Steinberger; Enrico Just; Jesse J Swen; Henk-Jan Guchelaar; Matthias Samwald
Journal:  J Am Med Inform Assoc       Date:  2018-07-01       Impact factor: 4.497

Review 4.  Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.

Authors:  Kristi Krebs; Lili Milani
Journal:  Hum Genomics       Date:  2019-08-27       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.